Revenue ($m): 351, up 27pc from year-earlier 275.8
Pretax profit ($m): 45.2 v year-earlier 35.3
Net profit ($m): 31.3 v year-earlier 23
Final dividend: 7¢, payable October 6
Integral Diagnostics (IDX) 2021 full year was impacted by COVID-19 outbreaks and lockdowns but it still managed to increase operating revenue and its bottom line by strong double digits.
The group provides diagnostic services at 67 radiology clinics, including 27 comprehensive sites, in Australia and New Zealand.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
